City of Hope
1500 E Duarte Rd
About City of Hope
City of Hope, an innovative biomedical research, treatment and educational institution with over 5,000 employees, is dedicated to the prevention and cure of cancer and other life-threatening diseases and guided by a compassionate, patient-centered philosophy.
Founded in 1913 and headquartered in Duarte, California, City of Hope is a remarkable non-profit institution, where compassion and advanced care go hand-in-hand with excellence in clinical and scientific research. City of Hope is a National Cancer Institute designated Comprehensive Cancer Center and a founding member of the National Comprehensive Cancer Network, an alliance of the nation’s 20 leading cancer centers that develops and institutes standards of care for cancer treatment.
Individually we are many things. Together, we are hope.
8 articles with City of Hope
City of Hope | South Bay Opens Today in the New $80 Million Providence Advanced Care Center in Torrance
One of the nation’s premier cancer centers now offers multidisciplinary cancer care in the region
The ever-changing Anthony F. Markel Family City of Hope Museum was named in honor of an insurance industry leader and his family
Real Estate Industry Luminary Yat-Pang Au of Veritas Investments To Be Honored with City of Hope’s Prestigious Spirit of Life® Award at Dinner Gala on Sept. 26
City of Hope’s Northern California Real Estate Council will honor Yat-Pang Au, chief executive officer of Veritas Investments, with its 2018 Spirit of Life® Award at its annual gala on Sept. 26, 2018, at the Fairmont Hotel.
Albertsons, Vons and Pavilions Stores Raise Over $1 Million for City of Hope’s Research and Treatment for Childhood Cancers
City of Hope’s annual Kids 4 Hope program, in partnership with Albertsons Companies Foundation, Vons Foundation and Pavilions Foundation, has raised over $1 million to support research and treatment for pediatric cancers.
Family of Beverly and Ben Horowitz Creates Fund at City of Hope to Advance Innovative CAR T Cell Therapy Research
In memory of Ben and Beverly Horowitz, longtime chief executive officer and first lady of City of Hope, their family has donated $1 million to City of Hope to help advance groundbreaking CAR T cell immunotherapy research to combat cancer.
City of Hope Appoints Jennifer Parkhurst as Chief Financial Officer and Mark Hulse as Chief Digital Officer
Both are members of City of Hope’s Enterprise Leadership Team and report directly to the institution’s President and Chief Executive Officer Robert W. Stone.
City of Hope Physicians Report on New CAR-T Cell Therapy for Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm at American Society of Hematology Annual Meeting
City of Hope patients whose acute myeloid leukemia (AML) was no longer responding to standard therapies and a patient with a rare blood cancer, blastic plasmacytoid dendritic cell neoplasm, achieved a complete response (cancer-free) after undergoing treatment with MB-102 CAR-T therapy, which targets CD123 cells.
City of Hope Physicians Present New CAR-T Cell Therapy Study Results and Other Research at 2017 American Society of Hematology Annual Meeting
The trials, presented by City of Hope physicians and researchers, could ultimately lead to innovative therapeutic approaches that improve treatment options and quality of life for patients with blood cancers and other diseases.